<DOC>
	<DOCNO>NCT00714519</DOCNO>
	<brief_summary>This study assess clinical trial regard heal partial thickness wound execute nursing home .</brief_summary>
	<brief_title>Feasibility Study Execution Efficacy Trial Nursing Home Setting</brief_title>
	<detailed_description>This study test efficacy XenadermÂ® vs. vehicle heal partial thickness wound caused pressure , moisture friction .</detailed_description>
	<mesh_term>Castor Oil</mesh_term>
	<criteria>1 . Provide write informed consent , consist reading , sign date informed consent document Investigator , subInvestigator designate study staff member explain study procedure , risk , contact information . If subject unable read sign inform consent , unable comprehend information provide consent process , legal guardian , decision making proxy , next kin must provide write consent , possible , subject must verbally assent receive experimental treatment wound . 2 . Are least 18 year age . 3 . Are expect remain Nursing Home duration study ( 22 day ) . 4 . Have one partialthickness wound ( include wound excoriation , erosion denude skin , ulceration subcutaneous fat , fascia , muscle , tendon bone visible ) trunk proximal extremity ( arm elbow , leg knee ) present least 2 day less 6 week ; measure great equal 2 less equal to40 cm2 total denude area ; , connect area erythema ( multiple wound ) . 5 . Are capable maintain adequate nutritional intake study . 6 . Are acceptable state health nutrition prealbumin level great equal 15 mg/dl ( 0.015g/l ) , serum albumin great equal 3.0 g/dl ( 30g/l ) , alkaline phosphatase great equal low limit normal , abnormal laboratory value , opinion Medical Supervisor , place subject risk study . 1 . Have 64 cm2 total denude wound area , include target nontarget wound . 2 . Have fullthickness wound within 4 cm target wound . 3 . Have clinical evidence bacterial fungal infection target wound . 4 . Have target wound ( ) involve tunnel , sinus track , shear injury , arterial occlusive disease bony prominence joint exception target wound may dorsal spinous process , coccyx , ischial tuberosity sacroiliac joint ( may full thickness ) . 5 . Are moribund , severe burn , immunodeficiency disorder , hematologic disorder , metastatic malignancy uncontrolled diabetes mellitus . 6 . Are know acrodermatitis enteropathica ( zinc deficiency ) . 7 . Are treated systemic steroid , immunosuppressive agent , radiation chemotherapy . 8 . Have treat enzymatic debridement target wound ( ) within 2 day prior enrollment . 9 . Have know sensitivity ingredient Xenaderm Ointment . 10 . Are use use another investigational agent ( include device hear aid , pace maker , etc . ) within 30 day prior Visit 1 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Xenaderm</keyword>
	<keyword>partial</keyword>
	<keyword>thickness</keyword>
	<keyword>wound</keyword>
	<keyword>Nursing Homes</keyword>
</DOC>